
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.

Christy Owings is Vice President and General Manager, Clinical Trials, Americas, at Thermo Fisher Scientific. With more than 20 years of progressive leadership experience in drug development support, 16 of them at Thermo Fisher Scientific, she has built deep expertise across quality assurance, client services, program management, sales and general management. In her current role, she leads 18 sites across North and South America, overseeing clinical trials services, global supply management, and government operations for the Americas region.

Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.

Christy Owings, Thermo Fisher, on why early supply chain partnership and site visits prevent costly eCOA and clinical trial delays.

Christy Owings, Thermo Fisher, on how AI complements clinical supply chain expertise, streamlines site logistics, and tracks shifting biotech markets.

Christy Owings, Thermo Fisher, speaks on why importer of record strategy and vetted local partners are key to reliable clinical trial supply chains.

Christy Owings, Thermo Fisher, discusses how customs delays and import complexity risk clinical trial supply chains in Latin America.